ClinicalTrials.gg
RecruitingNCT07496775ACOUTECTUpdated Oct 28, 2026

Cardiovascular Acoustics for Early Disease Detection

An observational study in Valvular Heart Disease and Coronary Artery Disease, sponsored by Cambridge University Hospitals NHS Foundation Trust. Recruiting at 1 site in United Kingdom. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-28.

Sponsored by Cambridge University Hospitals NHS Foundation Trust · Observational

How we know

From the registry’s dates

  • Started Jun 2026; still recruiting 5 months later.
Updated Oct 28, 2026Now RecruitingFirst site in United Kingdom+2 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
500
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 42 studies in Heart Valve Diseases with a site in United Kingdom — 16 open to participants now, 21 under way, none of them phase 3. Heart Valve Diseases · United Kingdom.

Planned enrollment
6th of 18
500 · median 400
Started
2026
the only one that year
Observational
18 of 42
8 open now
Primary completion
2027-12
later than 15 of 20 live
Registered
42nd of 42
by date
Lead sponsor
1 of 42
Cambridge University Hospitals NHS Foundation Trust

Among the 42 studies in Heart Valve Diseases with a site in United Kingdom, this one is the 6th largest by planned enrollment of the 18 observational ones that give a count, is the only one that started in 2026, is one of 18 observational ones, reaches primary completion later than 15 of the 20 other live ones, and was the 42nd registered.

Heart Valve Diseases

557 studies on the registry are indexed under Heart Valve Diseases; 167 are open to participants now.

Browse Heart Valve Diseases studies →

Open to participants now

16 of the 42 studies in Heart Valve Diseases with a site in United Kingdom are open now. Recruiting first, the newest first:

10 more — sign in →

All 16 open studies →

A study can be open while its sites in United Kingdom have not opened yet or have stopped. Only those recruiting at a site in United Kingdom →

Who these studies take

Of the 119 Heart Valve Diseases studies recruiting now, 94 (79%) set no upper age limit and 10 (8%) stop at 75 or younger; 16 take children under 18; 15 take healthy volunteers.

This study: 18 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 42 studies in Heart Valve Diseases with a site in United Kingdom, or all of them as a file.
02

Study summary

There are many types of heart disease. Two of the most common causes are narrowings within the blood vessels that supply the heart (known as coronary artery disease), or valves within the heart becoming narrowed (stenosed) or leaky (regurgitation), known as heart valve disease.

There are two main types of imaging used to test for these conditions. Coronary artery disease can be diagnosed by taking X-ray pictures of a dye when injected into the blood vessels. In some cases the dye is injected into the veins and a CT scanner is used (CT coronary angiography), in others the dye is injected via a tube placed in the artery (invasive coronary angiography). Valvular heart disease is normally diagnosed using an echocardiogram (ultrasound of the heart).

In this study the investigators are looking for subtle changes in the sounds that come from the heart, which may allow heart disease to be detected earlier. The investigators are using a novel device, similar to a digital stethoscope, that has excellent sensitivity for heart sounds. Ultimately this may be used in community settings including GP surgeries, in this study the investigators are collecting sounds from patients undergoing routine scans as part of their workup for heart disease.

03

Conditions studied

  • Valvular Heart Disease
  • Coronary Artery Disease

Keywords

  • coronary artery disease
  • valvular heart disease
  • ischemic heart disease
  • cardiovascular acoustics
  • heart sounds
  • cardiac auscultation
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Patients referred to Department of Cardiology, Cambridge University NHS Foundation Trust.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Participants aged ≥18 years
  • Able to provide written,
  • Has undergone angiography in the previous 6 months and scheduled to undergo transthoracic echocardiography, or has undergone transthoracic echocardiography in the previous 6 months and scheduled to undergo angiography, or is scheduled to undergo transthoracic echocardiography and angiography within 6 months.
  • Angiography and echocardiography performed within Cambridge University Hospitals NHS Foundation Trust.

Exclusion criteria

Exclusion Criteria:

  • Haemodynamic instability
  • STEMI or high risk NSTEMI
  • Anginal symptoms at rest
  • Heart failure symptoms with 4
  • Cardiovascular related admission or event occurring between imaging studies
  • Uncontrolled symptomatic arrhythmia
  • Acute pulmonary embolism
  • Acute aortic dissection
  • Previous valve intervention
  • Suspected endocarditis
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

NYHA class (heart failure)

The New York Heart Association’s four classes of how much heart failure limits physical activity.

I
No limits: ordinary activity causes no undue tiredness or breathlessness.
II
Slight limits: comfortable at rest, ordinary activity causes symptoms.
III
Marked limits: comfortable at rest, less than ordinary activity causes symptoms.
IV
Symptoms even at rest; any activity makes them worse.

Studies set their own limit — many outside heart failure leave out class III–IV, while heart failure studies may ask for a particular class. Check the class this study names.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
500 participants (estimated)
Patient registry
No

Groups and cohorts

  • Control

    No valvular heart disease, no coronary artery disease

  • Coronary artery disease

    Significant coronary artery disease, no valvular heart disease

  • Valvular heart disease

    Significant valvular heart disease, no coronary artery disease

  • Mixed disease

    Significant coronary artery disease and significant valvular heart disease

06

What researchers measure

Primary outcomes

  1. Discriminant score

    A discriminant score (minimum 0, maximum 1) for each of coronary artery disease and valvular heart disease will be generated by analysis of the phonographs.

    Time frame: Investigations to be performed within six (6) months of one another.

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Undecided — To reviewed following completion of pilot phase.

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jun 2026 (actual). Primary completion is estimated for Dec 2027, 18 months after the start.

Of 96 non-industry observational studies under Heart Valve Diseases, half reached primary completion within 67 months of starting (the median), counting those still running; a quarter within 23 and three quarters within 212. This study's planned 18 months is below that.

Counting every sponsor, half of 116 studies reached it within 67 months; a quarter within 29 and three quarters within 212.

Start moved once since we started tracking on Sep 25, 2026: May 2026 → Jun 2026, on Oct 28, 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Mar 23, 2026
First posted
Mar 27, 2026
StartActual
Jun 10, 2026was May 2026
Primary completionEst.
Dec 2027
CompletionEst.
Dec 31, 2029
Last update
Oct 28, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Recruiting
changed Oct 28, 2026
Sites
1 site added — first site in United Kingdom
Show site
  • Cambridge University NHS Foundation Trust · Cambridge, United Kingdom
Oct 28, 2026
Start date
May 1, 2026→Jun 10, 2026 (actual)
Oct 28, 2026
Show all 1 update
  1. Oct 28, 2026
    Not yet recruiting→Recruiting
    1 site added — first site in United Kingdom
    Show site
    • Cambridge University NHS Foundation Trust · Cambridge, United Kingdom
    Start date May 1, 2026→Jun 10, 2026 (now actual)
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07496775
Responsible party
Jacob Brubert (Academic Clinical Fellow, Cambridge University Hospitals NHS Foundation Trust) — Principal investigator
First posted
Mar 27, 2026
Start date
Jun 10, 2026
Primary completion
Dec 2027 (estimated)
Completion
Dec 31, 2029 (estimated)
Last update
Oct 28, 2026

Study contacts

Stephen Kelleher
Contact
cuh.research@nhs.net
01223 217418
James HF Rudd, PhD FRCP
principal investigator · University of Cambridge
Jacob B Brubert, PhD MRCP
study director · Cambridge University NHS Foundation Trust

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion